George H. Hitchings
For his leadership in the development of metabolic inhibitors by systematic chemical modification of biologically important compounds. Agents developed in this way have proven valuable in the treatment of malaria, gout, malignant diseases, disorders of the immune system, in human organ transplantation, and a variety of diseases.
Affilié au moment de l'attribution du prix
Tuckahoe, États-Unis